Company intelligence / Profile preview

Rava Company

South San Francisco, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Rava is a biotechnology company developing a high-throughput, single-molecule protein sequencing platform. The company's technology aims to provide a more comprehensive and sensitive view of the proteome compared to existing methods, enabling researchers to identify and quantify proteins at the single-molecule level. By leveraging advanced nanopore technology and proprietary biochemistry, Rava's platform is designed to accelerate biomarker discovery, drug development, and clinical diagnostics. The company is based in South San Francisco and is backed by leading venture capital firms in the life sciences space.

Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Rava Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rava Company.

Explore the full profile